High Content Ephedra Supplements Subject To Proposed DEA Controls
This article was originally published in The Tan Sheet
Executive Summary
Dietary supplements containing ephedrine and pseudoephedrine "mixtures" with more than 2% concentrations of either or both of the ingredients would be subject to Controlled Substances Act reporting and recordkeeping requirements under a proposed rule published by the Drug Enforcement Administration in the Sept. 16 Federal Register.